Cdk inhibitors and their use as pharmaceuticals
Номер патента: EP4263525A1
Опубликовано: 25-10-2023
Автор(ы): Andrew Paul Combs, Andrew W. Buesking, Katarina ROHLFING, Ryan Holmes, Sarah Pawley, Xiaowei Wu
Принадлежит: Prelude Therapeutics Inc
Опубликовано: 25-10-2023
Автор(ы): Andrew Paul Combs, Andrew W. Buesking, Katarina ROHLFING, Ryan Holmes, Sarah Pawley, Xiaowei Wu
Принадлежит: Prelude Therapeutics Inc
Реферат: The disclosure is directed to compounds of Formula (I), pharmaceutical compositions comprising compounds of Formula (I), as well as methods of their use and preparation, are also described.
Cdk inhibitors and their use as pharmaceuticals
Номер патента: AU2021401403A9. Автор: Xiaowei Wu,Andrew W. Buesking,Katarina ROHLFING,Andrew Paul Combs,Ryan Holmes,Sarah Pawley. Владелец: Prelude Therapeutics Inc. Дата публикации: 2024-10-24.